Skip to main content

Breaking Down mRNA Capping Efficiency with High-Resolution IP-RP LC

Evaluating 5′ capping efficiency is a critical quality attribute in therapeutic mRNA manufacturing, directly impacting translation efficiency and transcript stability. However, separating structurally similar capped, partially capped, and uncapped species differing by just a single nucleotide remains a significant chromatographic challenge.

Our latest Application Note highlights an optimized ion-pair reversed-phase liquid chromatography (IP-RP LC) method designed to tackle this complexity.

𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗕𝗶𝗼𝗶𝗻𝗲𝗿𝘁 𝗛𝗮𝗿𝗱𝘄𝗮𝗿𝗲: Utilizing the widepore YMC Accura Triart Bio C18 column to eliminate unwanted secondary interactions and deliver robust, reproducible results.

𝗦𝗲𝗮𝗺𝗹𝗲𝘀𝘀 𝗟𝗖-𝗠𝗦 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗶𝗼𝗻: Successfully applied to LC-MS workflows using mass-extracted ion chromatograms (MICs) to definitively differentiate between Cap-0, Cap-1, and critical uncapped impurities.

Read the complete application data  or reach out to our team to learn how to optimize your oligonucleotide and mRNA separations!

Posted on May 21, 2026.

Related Posts

June 18, 2026

Happy Retirement, John!

Today, we are celebrating John Heffernan, who is officially stepping into retirement after 16 years with YMC America. John’s journey with us actually began back when we were known as Integrated Process Technologies, long before we transitioned to YMC America. Over the years, John has worn many hats, from Project Manager to Estimating Manager, Engineering Manager, and ultimately Director of Business Development.

June 2, 2026

Chromatography of Biotherapeuticals – Analyzing and Purifying Peptides and Oligonucleotides

This webinar will highlight how advanced ultra-high-performance liquid chromatography (UHPLC) strategies, carefully selected stationary phases, and bioinert hardware can significantly improve the analysis and purification of peptides and oligonucleotides.

May 7, 2026

Revolutionizing CRISPR Applications: High-Resolution sgRNA Analysis

Ensuring the quality of single guide RNA (sgRNA) is a major hurdle in CRISPR-Cas genome editing. Because these molecules are large (~100mer) and prone to complex secondary structures, separating them from nearly identical impurities requires precision. Our latest application note

Designed and developed by